FindTrial
Sign In

The concurrent validity of surface EMG compared to intramusculair EMG of the multifidus activity.

The concurrent validity of surface EMG compared to intramusculair EMG of the multifidus activity. - Surface EMG vs. intramusculair EMG

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43365
Enrollment
30
Registered
2017-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-specific lower back pain

Interventions

intramusculair
multifidus
surface

Sponsors

anesthesiologie- onderzoeksbureau
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients • Between 18 and 65 years old • non-specific lower back pain • Patients with chronic non-specific lower back pain (>12 weeks) • Motivated for participation;Healthy subjects • Between 18 and 65 years old • Motivated for participation

Exclusion criteria

Exclusion criteria: Patients • Presence of red flags and lumbarsacral radicular syndrom • Pregnancy • Previous backsurgery • Psychiatric diagnosis • Insufficient knowledge of the Dutch language • Body mass index > 30;Healthy subjects • non-specific lower back pain • Presence of red flags and lumbarsacral radicular syndrom • Pregnancy • Previous backsurgery • Psychiatric diagnosis • Insufficient knowledge of the Dutch language • Body mass index > 30

Design outcomes

Primary

MeasureTime frame
The primary study parameter is the amount of EMG, with parameters relative rEMG, amplitud (mV), frequency amount (Fmed) in Hz. These parameters will be measured by surface and intramuscular EMG.—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)